Stock Events

Stock Events

Alnylam Pharmaceuticals (A1LN34.SA) Q3 2024 Earnings

1AugConfirmed

Q4 2023

Q1 2024

Q2 2024

Q3 2024

-6.54

-1.49

3.57

8.62

Details

Expected EPS

-6.1359937108

Actual EPS

-0.7475780000000001

Surprise EPS

5.39

Surprise Percent

+87.82%

Description

Alnylam Pharmaceuticals (A1LN34.SA) has reported earnings of -0.7475780000000001 per share for Q3 2024.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.